The CALR exon 9 mutations are shared neoantigens in patients with CALR mutant chronic myeloproliferative neoplasms

Leukemia. 2016 Dec;30(12):2413-2416. doi: 10.1038/leu.2016.233. Epub 2016 Aug 18.

Authors

M O Holmström^{1

2}, C H Riley¹, I M Svane², H C Hasselbalch¹, M H Andersen^{2

3}

Affiliations

¹ University Hospital Zealand, Roskilde, Denmark.
² Center for Cancer Immune Therapy, Department of Hematology, Copenhagen University Hospital at Herlev, Herlev, Denmark.
³ Department of Immunology and Microbiology, University of Copenhagen, Copenhagen, Denmark.

PMID: 27560107
DOI: 10.1038/leu.2016.233

No abstract available

Publication types

Letter
Research Support, Non-U.S. Gov't

MeSH terms

Amino Acid Sequence
Antigens, Neoplasm / genetics*
Calreticulin / chemistry
Calreticulin / genetics*
Enzyme-Linked Immunosorbent Assay
Exons*
Humans
Mutation*
Myeloproliferative Disorders / genetics*

Substances

Antigens, Neoplasm
Calreticulin